Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2020-10-07 2020-10-07
Drug Identification Number 02423766 02423766
Brand name MIDAZOLAM INJECTION MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM INJECTION MIDAZOLAM INJECTION
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MIDAZOLAM MIDAZOLAM
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 3mL ampoules 3mL ampoules
ATC code N05CD N05CD
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-04-30 2021-04-30
Remaining supply date 2021-04-30 2021-04-30
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments